Table 2. Baseline medications in the mono-therapy group and combination group.
| Drug classes | Mono-therapy group (n=32,682) |
Combination group (n=4,926) |
|||
|---|---|---|---|---|---|
| N | % | N | % | ||
| β-blockers | 3,696 | 11.31 | 0 | 0.00 | |
| CCB | 17,028 | 52.10 | 0 | 0.00 | |
| ACEI | 3,971 | 12.15 | 0 | 0.00 | |
| ARB | 6,119 | 18.72 | 0 | 0.00 | |
| Diuretics | 1,868 | 5.72 | 0 | 0.00 | |
| β-blocker + CCB | 0 | 0.00 | 1,085 | 22.03 | |
| β-blocker + ACEI | 0 | 0.00 | 124 | 2.52 | |
| β-blocker + ARB | 0 | 0.00 | 139 | 2.82 | |
| β-blocker + diuretics | 0 | 0.00 | 63 | 1.28 | |
| CCB + ACEI | 0 | 0.00 | 1,090 | 22.13 | |
| CCB + ARB | 0 | 0.00 | 1,933 | 39.24 | |
| CCB + diuretic | 0 | 0.00 | 285 | 5.79 | |
| ACEI + ARB | 0 | 0.00 | 33 | 0.67 | |
| ACEI + diuretic | 0 | 0.00 | 75 | 1.52 | |
| ARB + diuretic | 0 | 0.00 | 99 | 2.01 | |
Note: CCB, calcium channel blockers; ARB, angiotensin II receptor blockers; ACEI, angiotensin converting enzyme inhibitor.